Dataset Information


Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.

ABSTRACT: The inhibitory effects demonstrated by activation of cannabinoid receptors (CB) on cancer proliferation and migration may also play critical roles in controlling bladder cancer (BC). CB expression on human normal and BC specimens was tested by immunohistochemistry. Human BC cells RT4 and RT112 were challenged with CB agonists and assessed for proliferation, apoptosis, and motility. Cellular sphingolipids (SL) constitution and metabolism were evaluated after metabolic labelling. CB1-2 were detected in BC specimens, but only CB2 was more expressed in the tumour. Both cell lines expressed similar CB2. Exposure to CB2 agonists inhibited BC growth, down-modulated Akt, induced caspase 3-activation and modified SL metabolism. Baseline SL analysis in cell lines showed differences linked to unique migratory behaviours and cytoskeletal re-arrangements. CB2 activation changed the SL composition of more aggressive RT112 cells by reducing (p?


PROVIDER: S-EPMC5304189 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2007-01-01 | S-EPMC2190011 | BioStudies
2008-01-01 | S-EPMC2219529 | BioStudies
2008-01-01 | S-EPMC2219536 | BioStudies
2006-01-01 | S-EPMC1978428 | BioStudies
1000-01-01 | S-EPMC3148131 | BioStudies
1000-01-01 | S-EPMC4027495 | BioStudies
1000-01-01 | S-EPMC5356589 | BioStudies
2008-01-01 | S-EPMC2518473 | BioStudies
2010-01-01 | S-EPMC4033937 | BioStudies
2017-01-01 | S-EPMC5673238 | BioStudies